Berkshire Hathaway Shakes Up Portfolio with 26 Billion Delta Stake and Massive Alphabet Boost Mercurys Valuation Surges to 52 Billion as Fintech Recovery Gains Momentum Plus500 Reports 11 Quarterly Revenue Increase Reaffirms Market Expectations Snowflake Raises Revenue Forecast and Announces 6 Billion AWS Expansion as AI Demand Surges Young Directors Obsession Achieves 80x Budget Return Disrupting Hollywoods Remake Trend AXT Inc Shares Surge 157 Ahead of Anticipated Corporate Announcements HUBS Q1 2026 Earnings Earnings Beat Expectations with 8 Surprise HURA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biosciences Company Focuses on Pipeline Development Rigetti Computing Inc RGTI Q1 2026 Earnings NarrowerThanExpected Loss as Quantum Computing Firm Prepares for Commercial Scale BioVie Inc BIVI Q1 2026 Earnings Narrowing Losses and Clinical Progress Buoy Investor Sentiment Diamond Hill Investment Group Inc DHIL Q1 2025 Earnings Reported EPS of 323 Amid Stable Market Conditions Vistagen Therapeutics VTGN Q1 2026 Earnings Narrowing Loss Beats Estimates as Pipeline Progress Continues Bakkt BKKT Faces Selling Pressure as Shares Decline 357 Amid Volatile Trading Eastman Kodak KODK Falls 294 as Shares Test Key Support Near 941 SmartFinancial Inc SMBK Edges Higher as Support Holds Resistance Looms at 4359 Paramount Gold Nevada PZG Edges Lower as Key Support Levels Come into Focus Constellium CSTM Rallies 3 Approaching Key Resistance at 3673 Eaton Vance TaxAdvantage Global Dividend Opp ETO Edges Higher Testing Key Resistance Zone TG Therapeutics Inc TGTX Sees Gains as Price Approaches Key Resistance Level BioAtla Inc BCAB Edges Higher as Stock Tests Key Resistance Near 395 Pimco Global StocksPlus Income Fund PGP Edges Higher Amid Stabilizing Price Action Linde LIN Slips 12 as Defensive Positioning Wavers Key Support in Focus NexPoint Diversified Real Estate Trust NXDT Gains 4 as Rebound from Support Levels Continues SpaceX Successfully Launches Starship Test Flight After Initial Scrub CBOE Q1 2026 Earnings EPS Surges Past Estimates with 1028 Beat Anavex Life Sciences AVXL Edges Higher Amid Biotech Sector Rotation zSpace Q1 2026 Earnings EPS Misses Estimates by Wide Margin as Revenue Remains Absent PRCT Q1 2026 Earnings EPS Narrowly Beats Estimates as Stock Slips MKTW Q1 2026 Earnings Staggering EPS Miss and Lack of Revenue Disclosure Raise Concerns LINC Q1 2026 Earnings EPS Surpasses Estimates with 2111 Surprise NIC Q1 2026 Earnings Significant EPS Miss Triggers Negative Market Reaction REX Q3 2001 Earnings EPS Beats Estimates by 23 on Strong Operating Performance MDU Q1 2026 Earnings EPS Misses Estimates by 72 Stock Gains 15